ArticleTranslational cancer research2022

The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review.

Libin He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.